학술논문
Targeted delivery of doxorubicin into tumor cells to decrease the in vivo toxicity of glutathione-sensitive prodrug-poloxamer188-b-polycaprolactone nanoparticles and improve their anti-tumor activities
Document Type
Article
Author
Source
In Colloids and Surfaces B: Biointerfaces December 2022 220
Subject
Language
ISSN
0927-7765